You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
News on diagnostic systems for drugs of abuse and toxicology.
Prescient offers a test that is designed to determine an individual's risk of opioid addiction by analyzing 16 genes in the brain's reward pathway.
The firm plans to launch 10 new products next year, but analysts were cautious about Quidel's prospects moving forward.
Researchers associated with the International Cannabis Consortium and 23andMe found a causal relationship between schizophrenia and cannabis use.
The guidelines are the first to attempt to specify which drugs are appropriate to test for routinely, guideline authors say.
Prescient said the acquisition will expand its lab capabilities and enhance its relationships with local, regional, and national health insurers.
The World Health Organization will be providing low-cost COVID-19 tests to low- and middle-income nations, according to Reuters.
Nature News examines how the confirmation of Amy Coney Barrett to the US Supreme Court could affect scientific agencies.
Nobel Prize-winner Arthur Ashkin, who developed optical tweezers, has died at 98, the Washington Post reports.
In PNAS this week: altered gene expression in brain samples from Alzheimer's disease patients, effects of gene mutations found in bladder cancer, and more.
This webinar will outline the use of targeted protein degradation (TPD) to understand transcriptional processes at a high kinetic resolution.